A specific molecule produced by gut bacteria may increase the risk of Alzheimer’s disease and accelerate cognitive decline in dementia patients, according to new research published in Nature Communications. The findings reveal that imidazole propionate (ImP), a compound generated when certain intestinal microbes break down the essential amino acid histidine, can enter the bloodstream and travel to the brain. In mouse experiments, researchers observed that this compound increased the accumulation of abnormal beta-amyloid and tau proteins, which are primary hallmarks of Alzheimer’s disease that ultimately lead to neuron death.
Gut Bacteria Compound Linked to Brain Changes
Nearly a decade ago, University of Wisconsin-Madison professors Barbara Bendlin and Federico Rey discovered that the intestinal microbiome of people with Alzheimer’s disease differs significantly from that of healthy individuals. To investigate how these microbial differences affect neurological health, researchers focused on ImP. While ImP-producing bacteria are present in a large fraction of the population, their abundance varies widely among individuals, according to Rey. Previous studies have connected the compound to type 2 diabetes and coronary artery disease, but the recent study demonstrates that its reach extends to the brain.
Blood Molecule Levels Track Faster Cognitive Decline
To determine how the molecule affects humans, researchers analyzed blood samples from nearly 1,200 participants enrolled in the Wisconsin Registry for Alzheimer’s Prevention and studies at the Wisconsin Alzheimer’s Disease Research Center. Volunteers with higher blood concentrations of ImP showed a greater likelihood of displaying biological markers tied to abnormal proteins and impaired neuron function. Because these participants underwent regular cognitive testing over time, the team directly compared their molecular levels with changes in memory and thinking skills. The data showed that individuals with the highest ImP levels experienced much faster cognitive decline, as noted by Rey.
Genetic Variations Affecting ImP Levels
The research team also identified a specific genetic variation associated with substantially higher levels of ImP in the bloodstream, carried by approximately 43% of study participants. Scientists suspect this genetic difference alters how efficiently the kidneys clear ImP from the blood. This exact genetic variation has previously appeared in large-scale genetic studies linked to an increased risk of Alzheimer’s disease, providing a potential biological explanation for that connection.
Targeting ImP for Future Alzheimer’s Treatments
Because gut bacteria produce ImP while metabolizing histidine—an essential amino acid found in many protein-rich foods—reducing the compound through diet alone presents a major challenge. Bendlin explains that while general dietary improvements support overall health, eliminating foods like eggs or red meat is impractical because the body requires histidine. Instead, the discovery opens a potential pathway for targeted pharmacological treatments. Researchers suggest that developing a specific inhibitor to lower ImP in the blood could function similarly to statins used for managing cholesterol, ultimately lowering Alzheimer’s risk and slowing cognitive decline.
Frequently Asked Questions About Gut Bacteria and Alzheimer’s Risk
What is imidazole propionate (ImP)?
Imidazole propionate is a metabolite produced when certain gut bacteria generate energy from histidine, an essential amino acid found in protein-rich foods. Once produced in the digestive tract, it can enter the circulatory system and reach organs throughout the body, including the brain.
How does ImP affect the brain?
In animal studies conducted by the research team, ImP reaching the brain promoted the accumulation of abnormal tau and beta-amyloid proteins. These proteins are hallmark features of Alzheimer’s disease that eventually cause neurons to die.
Can diet changes prevent ImP-related cognitive decline?
Dietary modification is difficult because histidine is an essential nutrient found in many protein-containing foods required for human health. Rather than eliminating these foods, scientists are exploring potential drug treatments, such as blood-clearing inhibitors, to lower ImP levels.
Worth a look